Adjuvant chemotherapy for luminal A breast cancer: a prospective study comparing two popular chemotherapy regimens.

Onco Targets Ther · 2013 · PMC3745289 · PMID 23966793

Europe PMC DOI

hedged sentence

0.7200

closest p · 14.4× alpha

0.7200

boldest claim

The sentences

did not reach statistical significanceP = 0.72not close (p > 0.1)

5 Grade III–IV hematological toxicity was higher in our study in the FEC-100 arm, but did not reach statistical significance ( P = 0.72), coinciding with the data from TACT not reaching statistical significance, 5 though grade III–IV hematological toxicity was statistically higher ( P = 0.008) in the FEC-100 arm in the PACS trial, 6 possibly due to their larger sample size.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.